ResMed Inc (RMD)
231.43
-4.01
(-1.70%)
USD |
NYSE |
Nov 14, 16:00
228.97
-2.46
(-1.06%)
After-Hours: 20:00
ResMed Cash and Short Term Investments (Quarterly): 426.36M for Sept. 30, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 426.36M |
| June 30, 2024 | 238.36M |
| March 31, 2024 | 237.91M |
| December 31, 2023 | 210.25M |
| September 30, 2023 | 209.10M |
| June 30, 2023 | 227.89M |
| March 31, 2023 | 227.89M |
| December 31, 2022 | 253.20M |
| September 30, 2022 | 207.16M |
| June 30, 2022 | 273.71M |
| March 31, 2022 | 201.77M |
| December 31, 2021 | 194.48M |
| September 30, 2021 | 276.15M |
| June 30, 2021 | 295.28M |
| March 31, 2021 | 230.64M |
| December 31, 2020 | 255.86M |
| September 30, 2020 | 421.41M |
| June 30, 2020 | 463.16M |
| March 31, 2020 | 352.86M |
| December 31, 2019 | 204.10M |
| September 30, 2019 | 172.15M |
| June 30, 2019 | 147.13M |
| March 31, 2019 | 146.51M |
| December 31, 2018 | 149.47M |
| September 30, 2018 | 230.19M |
| Date | Value |
|---|---|
| June 30, 2018 | 188.70M |
| March 31, 2018 | 704.28M |
| December 31, 2017 | 858.90M |
| September 30, 2017 | 811.10M |
| June 30, 2017 | 821.94M |
| March 31, 2017 | 827.31M |
| December 31, 2016 | 788.15M |
| September 30, 2016 | 781.66M |
| June 30, 2016 | 731.43M |
| March 31, 2016 | 718.50M |
| December 31, 2015 | 658.80M |
| September 30, 2015 | 822.05M |
| June 30, 2015 | 717.25M |
| March 31, 2015 | 866.32M |
| December 31, 2014 | 880.70M |
| September 30, 2014 | 881.69M |
| June 30, 2014 | 905.73M |
| March 31, 2014 | 938.56M |
| December 31, 2013 | 972.68M |
| September 30, 2013 | 976.57M |
| June 30, 2013 | 876.05M |
| March 31, 2013 | 1.013B |
| December 31, 2012 | 958.28M |
| September 30, 2012 | 890.63M |
| June 30, 2012 | 809.54M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
194.48M
Minimum
Dec 2021
463.16M
Maximum
Jun 2020
270.38M
Average
238.14M
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Boston Scientific Corp | 2.502B |
| Globus Medical Inc | 694.71M |
| Abbott Laboratories | 7.788B |
| Becton Dickinson & Co | 2.162B |
| Integra Lifesciences Holdings Corp | 277.60M |